George V Migausky's Net Worth
$9.29 Million
Who is George V Migausky?
George V Migausky has an estimated net worth of $9.29 Million. This is based on reported shares across multiple companies, which include BIOVERIS CORP, REGENXBIO Inc., Immunovant, Inc., OCULAR THERAPEUTIX, INC, Dimension Therapeutics, Inc., ABEONA THERAPEUTICS INC., DYAX CORP, and IGEN INTERNATIONAL INC /DE.
SEC CIK
George V Migausky's CIK is 0001134365
Past Insider Trading and Trends
2016 was George V Migausky's most active year for acquiring shares with 13 total transactions. George V Migausky's most active month to acquire stocks was the month of January. 2004 was George V Migausky's most active year for disposing of shares, totalling 27 transactions. George V Migausky's most active month to dispose stocks was the month of January. 2016 saw George V Migausky paying a total of $2,525,117.10 for 712,694 shares, this is the most they've acquired in one year. In 2007 George V Migausky cashed out on 456,025 shares for a total of $2,881,537.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOVERIS CORP No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -140.70K |
$21.50 | -$3,025,050.00 |
0
|
Jun 26
| |||
Form 4
| -2.85% | -4.00K |
—
|
—
| 136.34K |
Jan 9
| |||
Form 4
| -3.26% | -4.73K |
—
|
—
| 140.34K |
Sep 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 14
| |||
Form 4
| -5.23% | -120.00K |
$16.16 | -$1,939,400.00 | 2.18M |
Feb 17 - Feb 18
| |||
Form 4
|
∞
| 265.06K |
—
|
—
| 265.06K |
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REGENXBIO Inc. (RGNX) Snapshot price: $11.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +73.74% | 4.79K |
—
|
—
| 11.29K |
May 31
| |||
Form 4
| +115.81% | 3.49K |
—
|
—
| 6.5K |
Jun 2
| |||
Form 4
|
∞
| 3.01K |
—
|
—
| 3.01K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Immunovant, Inc. (IMVT) Snapshot price: $34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.25% | 11.26K |
—
|
—
| 121.06K |
Apr 2
| |||
Form 4
| -10.37% | -12.70K |
$39.73 | -$504,567.30 | 109.81K |
Scheduled
|
Dec 1
| ||
Form 4
| +11.39% | 12.52K |
—
|
—
| 122.51K |
Apr 12
| |||
Form 4
| +23.68% | 21.06K |
—
|
—
| 109.98K |
Aug 17
| |||
Form 4
| +32.33% | 21.73K |
—
|
—
| 88.93K |
Jan 10
| |||
Form 4
| +11.63% | 7K |
$7.65 | $53,550.00 | 67.2K |
Aug 20
| |||
Form 4
| +34.68% | 15.5K |
—
|
—
| 60.2K |
Mar 19
| |||
Form 4
|
∞
| 24.7K |
—
|
—
| 24.7K |
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OCULAR THERAPEUTIX, INC (OCUL) Snapshot price: $8.39
Interim CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dimension Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||